The Pharmaceutical Journal
Vol 279 No 7482 p671
15 December 2007

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Bivalirudin alone for ACS

Bivalirudin alone produces similar outcomes after one year, in terms of death, myocardial infarction or unplanned revascularisation, as two anticoagulant regimens in patients with acute coronary syndromes who have undergone early invasive treatment.

The regimens were bivalirudin plus glycoprotein IIb/IIIa inhibitors and heparin plus glycoprotein IIb/IIIa inhibitors (JAMA 2007;298:2497).